Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria-3

<p><b>Copyright information:</b></p><p>Taken from "Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria"</p><p>http://www.malariajournal.com/content/7/1/3</p><p>Malaria Journal 2008;7():3-3.</p><p>Published online 7 Jan 2008</p><p>PMCID:PMC2257967.</p><p></p>eated with recombinant human Erythropoietin 200 U daily on day 4–7 show a similar drop on day 9–10, but recover afterwards (right graph). The data shown are representative for repeated experiments. The data presented are from one single experiment. Data for the treatment group is representative for mice that received rhEpo 50–200 U daily on day 4–5